The study will use a baseline dose that uses the non-psychoactive part of medicinal cannabis. (Supplied: BOD Australia)
An Australian-first trial using medicinal cannabis to treat returned servicemen and women suffering from post-traumatic stress disorder (PTSD) has been launched today that targets defence personnel who have not had a response to conventional treatments.
- Researchers are seeking 300 people to take part in the national trial, which has attracted attention from the veteran community
- The Australian Defence Force reports about 8.3 per cent of its members have experienced PTSD in the past 12 months
- The ADF says the rate among males is almost double the…